---
title: COVID-19, SARS-CoV-2, Hidroxicloroquina e muito mais
link: 
---

## Noticias

#### 1. [China Is Avoiding Blame by Trolling the World](/listas/covid-19/China-Is-Avoiding-Blame-by-Trolling-the-World.html)

Matéria falando sobre a China ser culpada pela disseminação muncial do SARS-CoV-2. E sobre a falta de transparência do partido comunista Chinês.


## Papers

1. Gautret P, Lagier JC, Parola P, et al. **Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial** [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;105949. doi:10.1016/j.ijantimicag.2020.105949.

    Esse foi o estudo francês responsável por causar todo o agitamento na ciência em busca de um remédio milagroso para curar a COVID-19. [Link para o PDF](/listas/covid-19/Hydroxychloroquine_final_frances.pdf)


2. Sahraei Z, Shabani M, Shokouhi S, Saffaei A. **Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine** [published online ahead of print, 2020 Mar 16]. Int J Antimicrob Agents. 2020;105945. doi:10.1016/j.ijantimicag.2020.105945.
3. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. Published 2020 Mar 13. doi:10.1186/s40779-020-00240-0.
4. Cheng, V. C., Lau, S. K., Woo, P. C., & Yuen, K. Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical microbiology reviews, 20(4), 660-694. https://doi.org10.1128/CMR.00023-07.
5. Menachery, V. D., Yount Jr, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., … & Randell, S. H. (2015). A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature medicine, 21(12), 1508. https://doi.org/10.1038/nm.3985.
6. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;(February):1–6.
7. Muniz-Rodriguez K, Chowell G, Cheung C-H, Jia D, Lai P-Y, Lee Y, et al. Epidemic doubling time of the COVID-19 epidemic by Chinese province. medRxiv Prepr. 2020;
8. Wang C, Liu L, Hao X, Guo H, Wang Q, Huang J, et al. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. medRxiv. 2020;